Product Information
ZITUVIO 25 MG TABLET is a brand product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $10.0564 per EA under NDC 70710124003. Its NADAC has been published 58 times since May 21, 2025.
Strength
25 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
70710124003
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
SITAGLIPTINApproval Type
New Drug (NDA)
FDA Application
NDA211566On Market Since
11/30/2023
Pharmacological Classes
Price Statistics
The NADAC for ZITUVIO 25 MG TABLET has been published 58 times since May 21, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $10.0564 per EA |
|---|---|
| All-time high | $10.1125 (Jun 11, 2025) |
| All-time low | $10.0279 (Aug 20, 2025) |
| 52-week high | $10.0999 |
| 52-week low | $10.0279 |
| Median price | $10.0543 |
| Average price | $10.0583 |
| Largest weekly change | -0.4% (Jul 23, 2025) |
| Weeks tracked | 58 |
| Tracking since | May 21, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Sitagliptin market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of ZITUVIO 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ZITUVIO 25 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $10.0564 per EA (NDC 70710124003), effective Jun 24, 2026.
How has the price of ZITUVIO 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for ZITUVIO 25 MG TABLET has held within roughly two percent of its current level. It has been tracked across 58 weekly CMS publications since May 21, 2025.
What are the highest and lowest recorded NADAC prices for ZITUVIO 25 MG TABLET?
Since May 21, 2025, the NADAC for ZITUVIO 25 MG TABLET has ranged from a low of $10.0279 (Aug 20, 2025) to a high of $10.1125 (Jun 11, 2025), with a median of $10.0543 per EA.
Are there cheaper alternatives to ZITUVIO 25 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of ZITUVIO 25 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures ZITUVIO 25 MG TABLET?
ZITUVIO 25 MG TABLET (NDC 70710124003) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification